T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.97B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.37B |
| 3 |
lululemon athletica
LULU
|
+$1.32B |
| 4 |
Spotify
SPOT
|
+$1.28B |
| 5 |
ServiceNow
NOW
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$3.41B |
| 2 |
Northrop Grumman
NOC
|
+$2.36B |
| 3 |
Microsoft
MSFT
|
+$2.2B |
| 4 |
McDonald's
MCD
|
+$1.85B |
| 5 |
Intercontinental Exchange
ICE
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.34% |
| 2 | Healthcare | 16.78% |
| 3 | Financials | 13.77% |
| 4 | Consumer Discretionary | 12.98% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRE
1001
DELISTED
Duke Realty Corp.
DRE
| $37.8M | ﹤0.01% |
1,088,967
+53,084
| +5% | +$1.83M |
|
|
TRHC
1002
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $37.6M | ﹤0.01% |
773,134
-573,036
| -43% | -$26.8M |
|
1003
Blue Bird Corp
BLBD
$2.04B
| $37.5M | ﹤0.01% |
1,636,771
+2,850
| +0.2% | +$56.9K |
|
1004
Tetra Tech
TTEK
$9.09B
| $37.5M | ﹤0.01% |
2,175,340
+2,031,065
| +1,408% | +$35.2M |
|
1005
Tenable Holdings
TENB
$4.41B
| $37.4M | ﹤0.01% |
1,561,882
+783,398
| +101% | +$19.1M |
|
1006
Barclays
BCS
$94.4B
| $37.2M | ﹤0.01% |
3,908,258
+123,621
| +3% | +$1.07M |
|
1007
Urban Edge Properties
UE
$2.75B
| $37.2M | ﹤0.01% |
1,938,740
-682,227
| -26% | -$13.8M |
|
1008
iHeartMedia
IHRT
$450M
| $37.1M | ﹤0.01% |
2,197,396
-13,075
| -0.6% | -$198K |
|
1009
Kraft Heinz
KHC
$29.1B
| $37.1M | ﹤0.01% |
1,154,009
+10,071
| +0.9% | +$305K |
|
|
CATM
1010
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $37M | ﹤0.01% |
828,297
-4,493
| -0.5% | -$171K |
|
1011
CrowdStrike
CRWD
$230B
| $36.6M | ﹤0.01% |
2,934,348
+2,754,324
| +1,530% | +$36.1M |
|
1012
Best Buy
BBY
$17.5B
| $36.6M | ﹤0.01% |
416,641
-4,982
| -1% | -$381K |
|
1013
Molson Coors Class B
TAP
$7.75B
| $36.3M | ﹤0.01% |
672,718
+327,898
| +95% | +$17.6M |
|
1014
Huntington Ingalls Industries
HII
$12.9B
| $35.9M | ﹤0.01% |
142,939
-8,144
| -5% | -$1.93M |
|
1015
Five Below
FIVE
$13.2B
| $35.7M | ﹤0.01% |
278,937
+14,371
| +5% | +$1.8M |
|
|
FTSV
1016
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $35.5M | ﹤0.01% |
902,825
+402,670
| +81% | +$6.47M |
|
|
NEE.PRO
1017
DELISTED
NextEra Energy, Inc. 4.872% Corporate Units
NEE.PRO
| $35.5M | ﹤0.01% |
696,600
-500
| -0.1% | -$25.1K |
|
1018
Universal Health Services
UHS
$10.2B
| $35.5M | ﹤0.01% |
247,286
-6,966
| -3% | -$993K |
|
1019
uniQure
QURE
$3.26B
| $35.3M | ﹤0.01% |
492,926
+145,830
| +42% | +$8.01M |
|
1020
Employers Holdings
EIG
$864M
| $35.3M | ﹤0.01% |
845,134
+1,429
| +0.2% | +$60.7K |
|
|
IGMS
1021
DELISTED
IGM Biosciences
IGMS
| $35M | ﹤0.01% |
917,521
+102,242
| +13% | +$2.57M |
|
|
MCF
1022
DELISTED
Contango Oil & Gas Co.
MCF
| $34.9M | ﹤0.01% |
+10,002,390
| New | +$29.4M |
|
1023
Prestige Consumer Healthcare
PBH
$2.43B
| $34.9M | ﹤0.01% |
860,762
-61,101
| -7% | -$2.28M |
|
|
ODT
1024
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $34.9M | ﹤0.01% |
1,073,981
+7,661
| +0.7% | +$237K |
|
1025
Ligand Pharmaceuticals
LGND
$5.76B
| $34.7M | ﹤0.01% |
532,797
-14,603
| -3% | -$976K |
|
Similar funds
T. Rowe Price Associates's Q4 2019 Portfolio in Review
As of Q4 2019, T. Rowe Price Associates held 2,605 positions worth $771B, up 9.2% from $706B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
T. Rowe Price Associates's Q4 2019 filing shows 87 new, 1,561 increased, 802 reduced and 81 closed positions. Its largest new stake was XP: 7,905,172 shares worth $305M. The largest sale was Boeing, an estimated $3.41B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2019 buy was XP: 7,905,172 shares worth $305M.
- T. Rowe Price Associates added most to Apple in Q4 2019, an estimated $6.97B increase.
- T. Rowe Price Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $3.41B.
- T. Rowe Price Associates fully exited Viacom Inc. Class B in Q4 2019, selling an estimated $204M.
- T. Rowe Price Associates's ten largest holdings make up 22% of its $771B portfolio in Q4 2019.
- T. Rowe Price Associates opened 87 new positions and closed 81 in Q4 2019.
- T. Rowe Price Associates's portfolio value rose 9.2% quarter-over-quarter to $771B.
Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.